Literature DB >> 22203920

Translating cell survival and cell longevity into treatment strategies with SIRT1.

K Maiese1, Z Z Chong, Yan Chen Shang, S Wang.   

Abstract

The sirtuin SIRT1, a class III NAD(+)-dependent protein histone deacetylase, is present throughout the body that involves cells of the central nervous system, immune system, cardiovascular system, and the musculoskeletal system. SIRT1 has broad biological effects that affect cellular metabolism as well as cellular survival and longevity that can impact both acute and chronic disease processes that involve neurodegenerative disease, diabetes mellitus, cardiovascular disease, and cancer. Given the intricate relationship SIRT1 holds with a host of signal transduction pathways ranging from transcription factors, such as forkhead, to cytokines and growth factors, such as erythropoietin, it becomes critical to elucidate the cellular pathways of SIRT1 to safely and effectively develop and translate novel avenues of treatment for multiple disease entities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203920      PMCID: PMC3253557     

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  246 in total

1.  Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition.

Authors:  A Witting; P Müller; A Herrmann; H Kettenmann; C Nolte
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

2.  White matter protection by erythropoietin: an emerging matter in the treatment of neonatal hypoxic-ischemic brain injury.

Authors:  Sermin Genc; Kursad Genc; Abdullah Kumral; Hasan Ozkan
Journal:  Stroke       Date:  2010-09-30       Impact factor: 7.914

Review 3.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

4.  Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus.

Authors:  Sevil Kurban; Idris Mehmetoglu; Hümeyra F Yerlikaya; Sait Gönen; Sami Erdem
Journal:  Endocr Res       Date:  2011       Impact factor: 1.720

5.  2-methoxyestradiol attenuates autophagy activation after global ischemia.

Authors:  Xiao-Yu Xin; Jing Pan; Xiao-Qiang Wang; Jian-Fang Ma; Jian-Qing Ding; Guo-Yuan Yang; Sheng-Di Chen
Journal:  Can J Neurol Sci       Date:  2011-07       Impact factor: 2.104

6.  Development of an in vitro model of myotube ischemia.

Authors:  Dhiraj Joshi; Hemanshu Patel; Daryll M Baker; Xu Shiwen; David J Abraham; Janice C Tsui
Journal:  Lab Invest       Date:  2011-05-23       Impact factor: 5.662

Review 7.  Protective roles of SIRT1 in atherosclerosis.

Authors:  Sokrates Stein; Christian M Matter
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

8.  Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia.

Authors:  S Dernek; M Ikizler; N Erkasap; B Ergun; T Koken; K Yilmaz; B Sevin; Z Kaygisiz; T Kural
Journal:  Scand Cardiovasc J       Date:  2004-08       Impact factor: 1.589

9.  Therapeutic effects of erythropoietin in murine models of endotoxin shock.

Authors:  Kazutetsu Aoshiba; Shigemitsu Onizawa; Takao Tsuji; Atsushi Nagai
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

10.  SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.

Authors:  Takeshi Yoshizaki; Jill C Milne; Takeshi Imamura; Simon Schenk; Noriyuki Sonoda; Jennie L Babendure; Juu-Chin Lu; Jesse J Smith; Michael R Jirousek; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

View more
  43 in total

1.  Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL.

Authors:  Shaohui Wang; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2012-02       Impact factor: 1.990

Review 2.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

3.  A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Future Neurol       Date:  2012-11

Review 4.  Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 5.  Novel directions for diabetes mellitus drug discovery.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Expert Opin Drug Discov       Date:  2012-10-24       Impact factor: 6.098

6.  Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

Review 7.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

Review 8.  Brain activation of SIRT1: role in neuropathology.

Authors:  Alanna Fernandes Paraíso; Keila Lopes Mendes; Sergio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2013-04-25       Impact factor: 5.590

9.  WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1.

Authors:  Shaohui Wang; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2013-02       Impact factor: 1.990

Review 10.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.